Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.23 - $4.38 $78,946 - $155,060
35,402 New
35,402 $82,000
Q3 2023

Nov 14, 2023

BUY
$3.17 - $5.96 $39,308 - $73,904
12,400 Added 87.94%
26,500 $84,000
Q2 2023

Aug 14, 2023

BUY
$4.53 - $6.74 $63,873 - $95,034
14,100 New
14,100 $70,000
Q2 2022

Aug 15, 2022

SELL
$6.78 - $12.28 $206,112 - $373,312
-30,400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.65 - $15.29 $232,560 - $464,816
30,400 New
30,400 $277,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.